186 related articles for article (PubMed ID: 15117898)
1. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice.
Meirow D; Assad G; Dor J; Rabinovici J
Hum Reprod; 2004 Jun; 19(6):1294-9. PubMed ID: 15117898
[TBL] [Abstract][Full Text] [Related]
2. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
Huang YH; Zhao XJ; Zhang QH; Xin XY
Gynecol Oncol; 2009 Feb; 112(2):409-14. PubMed ID: 19038435
[TBL] [Abstract][Full Text] [Related]
3. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists.
Danforth DR; Arbogast LK; Friedman CI
Fertil Steril; 2005 May; 83(5):1333-8. PubMed ID: 15866565
[TBL] [Abstract][Full Text] [Related]
4. GnRH antagonist cetrorelix inhibits mitochondria-dependent apoptosis triggered by chemotherapy in granulosa cells of rats.
Zhao XJ; Huang YH; Yu YC; Xin XY
Gynecol Oncol; 2010 Jul; 118(1):69-75. PubMed ID: 20417958
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cyclophosphamide-induced ovarian damage by concomitant administration of GnRHa in mice: a dose-dependent relationship?
Yüce MA; Balkanli Kaplan P; Gücer F; Doğanay L; Altaner S; Canda T; Yardim T
Eur J Gynaecol Oncol; 2004; 25(5):628-31. PubMed ID: 15493183
[TBL] [Abstract][Full Text] [Related]
6. Is anti-Müllerian hormone a marker of acute cyclophosphamide-induced ovarian follicular destruction in mice pretreated with cetrorelix?
Browne HN; Moon KS; Mumford SL; Schisterman EF; Decherney AH; Segars JH; Armstrong AY
Fertil Steril; 2011 Jul; 96(1):180-186.e2. PubMed ID: 21550044
[TBL] [Abstract][Full Text] [Related]
7. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
8. [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].
Zhang Y; Lu ZY; Yan XH; Wang JJ; Feng WW; Ding JX; Hua Kq
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):892-7. PubMed ID: 22333277
[TBL] [Abstract][Full Text] [Related]
9. Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study.
Maman E; Prokopis K; Levron J; Carmely A; Dor J; Meirow D
Hum Reprod; 2009 Jan; 24(1):206-10. PubMed ID: 18854408
[TBL] [Abstract][Full Text] [Related]
10. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
Li X; Kang X; Deng Q; Cai J; Wang Z
Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone (GnRH) analogues and the ovary: do GnRH antagonists destroy primordial follicles?
Gupta RK; Flaws JA
Fertil Steril; 2005 May; 83(5):1339-42. PubMed ID: 15866566
[TBL] [Abstract][Full Text] [Related]
12. Both in vivo FSH depletion and follicular exposure to Gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice.
Horicks F; Van Den Steen G; Gervy C; Clarke HJ; Demeestere I
Mol Hum Reprod; 2018 Apr; 24(4):221-232. PubMed ID: 29438534
[TBL] [Abstract][Full Text] [Related]
13. Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model.
Horicks F; Van Den Steen G; Houben S; Englert Y; Demeestere I
PLoS One; 2015; 10(9):e0137164. PubMed ID: 26325271
[TBL] [Abstract][Full Text] [Related]
14. Absence of testicular protection by a gonadotropin-releasing hormone analogue against cyclophosphamide-induced testicular cytotoxicity in the mouse.
da Cunha MF; Meistrich ML; Nader S
Cancer Res; 1987 Feb; 47(4):1093-7. PubMed ID: 3542201
[TBL] [Abstract][Full Text] [Related]
15. Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve.
Kashi O; Roness H; Spector I; Derech-Haim S; Meirow D
Hum Reprod; 2023 Jun; 38(6):1086-1098. PubMed ID: 37015102
[TBL] [Abstract][Full Text] [Related]
16. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
[TBL] [Abstract][Full Text] [Related]
17. GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?
Parlakgumus HA; Kilicdag EB; Bolat FA; Haydardedeoglu B; Parlakgumus A
Arch Gynecol Obstet; 2015 Jun; 291(6):1403-10. PubMed ID: 25472738
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
[TBL] [Abstract][Full Text] [Related]
19. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
20. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice.
Kishk EA; Mohammed Ali MH
Arch Gynecol Obstet; 2013 May; 287(5):1023-9. PubMed ID: 23224696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
